Edited by Peter Hillerberg7 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
The week ahead in one paragraph: Q3 earnings season kicks off in earnest with the biggest US banks reporting Tuesday through Thursday. JPMorgan, Goldman Sachs, Wells Fargo, and Citigroup all report Tuesday; Bank of America and Morgan Stanley follow Wednesday and Thursday respectively. TSMC reports Thursday in what will be the first major read on semiconductor demand. The macro calendar is lighter on the US side, with Columbus Day closing bond markets Monday, but China's September CPI, PPI, and trade data land Wednesday. Multiple Fed and ECB speakers are scheduled throughout the week, keeping rate expectations in focus. Several signal-driven names from last week remain live, with short interest builds and cost-to-borrow surges in healthcare and tech still active.
Monday is Columbus Day in the US. Bond markets are closed. US equity markets trade normally, but Treasury auctions and some data releases shift.
Germany CPI (Tuesday, 8:00 AM CET): The final September reading is expected at 3.3% year on year, up from 2.9% in August. The harmonised measure carries the same expectation. A print at or above consensus would reinforce ECB caution on further easing. ECB speakers are active all week: Elderson and Lane speak Tuesday, Lagarde speaks Wednesday, Elderson and Buch again on Wednesday.
China CPI, PPI, and trade data (Wednesday): September CPI is expected at 1.0% year on year, up from 0.8%. PPI is expected at 4.5%, up from 3.8% in August. Exports are expected up 25.3% year on year, roughly flat with the 25.0% prior reading. Imports are expected at 23.5%, down from 28.2%. Vehicle sales (also Wednesday) had been running negative 5.1% the prior month. This batch matters for commodity-exposed sectors and any name with Asia supply chain exposure.
Fed speakers throughout the week: Hammack speaks Monday, Waller and Barkin on Tuesday, Collins also Tuesday. No rate decision this week, but the density of Fed commentary will keep markets attentive to any tonal shift.
NFIB Business Optimism (Tuesday): Expected at 98, marginally below the prior 98.7. A miss would add to concerns about small business confidence ahead of a busy earnings period.
Non-earnings catalysts: NVDA presents at Data Center World Europe in Frankfurt on Tuesday and Wednesday, and at AIM Summit Dubai on Tuesday. GOOGL, MSFT, and NVDA all present at Data Center World Europe, keeping AI infrastructure in the spotlight. AMAT and MRVL present at SEMICON West and OCP Global Summit respectively, two venues that typically surface forward demand signals for semis. PANW, CRWD, and FTNT all speak at GovWare 2026 in Singapore this week. Cybersecurity government demand is under close watch.
JPM, JPMorgan Chase, Tuesday The largest US bank by market cap ($885B) reports Q3 at 7:00 AM ET Tuesday. JPMorgan also presents at the CAIS Summit this week. The event note flags JPMorgan as the first major bank print of the week. Watch net interest income guidance for signals on rate sensitivity heading into any Fed moves.
GS, Goldman Sachs, Tuesday Goldman ($271B market cap) reports Tuesday morning alongside JPMorgan. Goldman also presents at the Fortune Most Powerful Women Summit and the CAIS Summit. Investment banking revenue and trading will be the focal points after a strong first half for M&A activity.
WFC, Wells Fargo, Tuesday Wells Fargo ($253B) reports Tuesday. Last week an open convergence flagged WFC with options swinging to calls even as Wall Street cut targets pre-earnings. The put-call ratio divergence entering the print is worth watching.
C, Citigroup, Tuesday Citigroup ($217B) reports Tuesday. Its ongoing restructuring program makes each quarterly print a reference point for progress on margin targets and headcount reduction.
BAC, Bank of America, Wednesday The event note flags Bank of America as "the largest single print of the week" at a $380B market cap. The call is at 6:45 AM ET Wednesday. Bank of America and Morgan Stanley both present at the CAIS Summit running Monday through Thursday. Net interest margin trajectory will set the tone for the rest of the week's bank prints.
MS, Morgan Stanley, Wednesday Morgan Stanley ($298B) reports Wednesday. Wealth management revenues and private credit AUM growth are the key metrics after several quarters of repositioning.
TSM, TSMC, Thursday Taiwan Semiconductor ($2.07T market cap) reports Q3 on Thursday. This is the most consequential non-financial print of the week. TSMC's revenue guidance will be read directly against AI chip demand expectations and feeds into how investors position in NVDA, AMAT, and MRVL. China CPI and PPI Wednesday morning will set part of the backdrop for reading TSMC's Asia demand commentary.
ASML, ASML Holding, Wednesday ASML ($689B) reports Q3 on Wednesday. Bookings are the number that moves markets here. ASML's order intake is a leading indicator for the entire semiconductor equipment cycle. AMAT presents at SEMICON West the same week, making this a dense window for semi equipment reads.
BLK, BlackRock, Wednesday BlackRock ($168B) reports Q3 Wednesday. AUM flows and fee revenue will be scrutinised. BlackRock also presents at the Bloomberg New Economy Forum and at GovWare this week.
UNH, UnitedHealth Group, Tuesday UnitedHealth ($340B) reports Monday/Tuesday. The event note flags UNH as one of the largest prints at the open of the week, alongside JNJ. Managed care sector signals from UNH will be read alongside recent upgrades in the HUM complex.
PS, Pershing Square Inc. Four signals are converging: analyst, options, short interest, and utilization. Short interest jumped 986% over one month. Cost to borrow sits at 240.97%, up 456% over the month. Utilization is at 90.31%. Availability has fallen to 11.2% of SI. Options PCR is 2.0, a z-score of 2.08 above the 20-day mean. Citigroup downgraded to Sell last Thursday with a $45 target, against a last close of $54.59. ORTEX's Rebalance Radar puts the probability of a Russell 1000 addition at 68%, with an announcement date of November 13. That is a forecast, not a confirmed event. Watch borrow availability: it collapsed 66% in a week.
MMED, MiniMed Group, Inc. Three signals active: CTB, short interest, and utilization. Utilization hit 100%. Cost to borrow surged 231% in one week to 62.19%. Availability dropped 66.8% in a week, now at just 0.50% of SI. Short interest is up 232% over one month at 25.4M shares. Days to cover stand at 5.89. The critical pulse this morning flagged MMED as the most extreme utilisation read in the current batch.
OPCH, Option Care Health Five analyst downgrades landed in a single day last Tuesday as the stock rallied 37% in a week. The convergence of analyst, CTB, and options signals remains open. PCR sits at 0.20, a z-score of 2.16 above the 20-day mean, flagging elevated call activity relative to recent norms despite the analyst headwinds. Short interest has fallen 32% over one month to 4.9% of float. ORTEX's Rebalance Radar puts the probability of an S&P MidCap 400 deletion at 80%, announced March 2027. That is a forecast.
BSP, Bending Spoons S.p.A. CTB, short interest, and utilization signals are all active. Utilization is at 100%. Cost to borrow surged 214% in one week to 26.48%. Short interest is up 40% over one month. Days to cover are 6.82. The stock rose 18.7% in one week but has given back 2.7% over one month. Analyst mean target stands at $47.67 against a last close of $38.01.
ASTS, AST SpaceMobile Analyst, options, and utilization signals are live. Short interest is 23.9% of float. The stock fell 10.5% in one day Friday and is down 22.9% over one month. Utilization is at 92.17%, near the 52-week high. Availability jumped 932% in one week to 9.4% of SI, suggesting some covering activity. Analyst mean target is $78.48 against a close of $50.97. ORTEX Rebalance Radar puts the probability of a CRSP US Small addition at 60% and CRSP US Large deletion at 60%, with a December 7 announcement date. These are forecasts.
Financials: coordinated setup into earnings JPMorgan, Goldman, Wells Fargo, Citigroup, Bank of America, Morgan Stanley, BlackRock, and Charles Schwab all report this week. Last week saw a convergence flagged on WFC with options swinging to calls as analysts cut targets. Raymond James ran a sweep of regional bank upgrades and downgrades on October 6 (ONB to Outperform, FULT to Market Perform, HTH to Underperform). The sector enters its heaviest reporting week with bond markets closed Monday, compressing price discovery into a four-day window.
Semiconductors: TSMC and ASML bookend the week TSMC reports Thursday. ASML reports Wednesday. AMAT presents at SEMICON West all week. Marvell presents at OCP Global Summit. NVDA, Alphabet, and Microsoft all speak at Data Center World Europe. This is the densest convergence of semi and AI infrastructure events in the calendar. Citigroup last week downgraded NVMI (target cut 24.5% to $415) and NXPI (target cut 30% to $260), both in the chip ecosystem. China's September PPI on Wednesday (expected 4.5% vs 3.8% prior) will be read as a demand signal for industrial and tech components.
Healthcare and managed care: signals active UNH and JNJ both report Tuesday. HUM received upgrades from both Cantor Fitzgerald and Baird last week, with targets raised sharply on Medicare Advantage margin recovery. MMED (MiniMed) has a critical utilization and borrow setup as described above. OPCH's convergence remains open. The sector has had high pulse density over the past week.
Three threads matter most this week. First, whether the big bank prints confirm net interest income has stabilised. BAC Wednesday is the pivotal number. Second, ASML bookings Wednesday and TSMC guidance Thursday: together they will set the tone for how the market reads AI capex demand into year-end. Third, China's Wednesday data batch (CPI, PPI, trade) arrives ahead of TSMC's call and will feed directly into how investors size macro risk against the AI infrastructure thesis. Any surprise on China exports or PPI shifts the context for every semiconductor name on the calendar.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
